BlackRock Group’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$3.72M Buy
20,216
+6,999
+53% +$1.29M ﹤0.01% 1338
2016
Q3
$3.41M Buy
13,217
+681
+5% +$175K ﹤0.01% 1289
2016
Q2
$2.68M Buy
12,536
+856
+7% +$183K ﹤0.01% 1373
2016
Q1
$2.41M Buy
11,680
+956
+9% +$197K ﹤0.01% 1419
2015
Q4
$2.71M Buy
10,724
+132
+1% +$33.4K ﹤0.01% 1323
2015
Q3
$1.74M Sell
10,592
-1,594
-13% -$262K ﹤0.01% 1572
2015
Q2
$2.29M Buy
12,186
+7,642
+168% +$1.43M ﹤0.01% 1478
2015
Q1
$750K Buy
4,544
+545
+14% +$90K ﹤0.01% 2015
2014
Q4
$930K Buy
3,999
+140
+4% +$32.6K ﹤0.01% 1916
2014
Q3
$698K Buy
3,859
+455
+13% +$82.3K ﹤0.01% 1987
2014
Q2
$655K Sell
3,404
-4,450
-57% -$856K ﹤0.01% 2045
2014
Q1
$1.43M Buy
7,854
+184
+2% +$33.5K ﹤0.01% 1784
2013
Q4
$1.31M Buy
7,670
+336
+5% +$57.2K ﹤0.01% 1795
2013
Q3
$1.15M Hold
7,334
﹤0.01% 1811
2013
Q2
$1.27M Buy
+7,334
New +$1.27M ﹤0.01% 1566